Prestige Consumer Healthcare (PBH) reported $1.1B in revenue for fiscal 2025, −4.3% year on year. That ranks #1722 by revenue among 2853 SEC filers and #157 in Healthcare. Net income was $190M, a net margin of 17.5%. Revenue has grown 4.5% a year on average since 2012 ($617M then). The fiscal 2025 balance sheet shows $3.5B in total assets, $62.4M in cash and $1.0B in long-term debt.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $1.1B | −4.3% | FY20252026-03-31 |
| Gross profitGrossProfit | $596M | −6.1% | FY20252026-03-31 |
| Operating incomeOperatingIncomeLoss | $309M | −8.1% | FY20252026-03-31 |
| Net incomeNetIncomeLoss | $190M | −11.3% | FY20252026-03-31 |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $258M | +2.4% | FY20252026-03-31 |
| Capital expenditurePaymentsToAcquirePropertyPlantAndEquipment | $11.2M | +35.9% | FY20252026-03-31 |
| Total assetsAssets | $3.5B | +5.0% | FY20252025-12-31 |
| Shareholders' equityStockholdersEquity | $1.8B | +2.3% | FY20252025-12-31 |
| CashCashAndCashEquivalentsAtCarryingValue | $62.4M | +22.6% | FY20252025-12-31 |
| Long-term debtLongTermDebt | $1.0B | +3.4% | FY20252025-12-31 |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Reported since the last full year
Three-month figures this company has filed since FY2025. A quarter is not comparable with a full year, and these figures are used nowhere else on the site: not in any ranking, not in comparisons, not in the download.
| Quarter | Revenue | Net income | Source |
|---|---|---|---|
| Q2 20262026-06-30 | $266M | $29.2M | Open → |
Only periods that end on a calendar quarter appear here. A company whose fiscal year ends in June files on a different calendar, so it has no row.
Where this sits in its sector
Each bar is the spread of the whole sector: the box covers the middle half of companies, the line inside it the median, and the triangle this company. The axis is clipped at the 5th and 95th percentile so a single outlier does not flatten it.
| Where this sits in its sector | FY2025 | Position in sector |
|---|---|---|
| Net marginRank 31 of 161 companies compared | 17.5% | |
| Operating marginRank 19 of 160 companies compared | 28.4% | |
| Cash as share of revenueRank 118 of 160 companies compared | 5.7% |
All four are ratios derived from two reported lines, not single filing items. Peer group: companies in the same sector with revenue of $1bn or more; loss-making companies are included.
Profile
- Legal name
- Prestige Consumer Healthcare Inc.
- Ticker
- PBH
- Exchange
- NYSE
- SIC classification
- Pharmaceutical Preparations (2834)
- Fiscal year end
- 03-31
- CIK
- 0001295947
Filings
- 10-QAug 6, 2026Open filing →
- 10-KMay 14, 2026Open filing →
- 10-QFeb 5, 2026Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| Trulieve CannabisTRLV | $1.2B | −$116M |
| Sotera HealthSHC | $1.2B | $77.9M |
| NovavaxNVAX | $1.1B | $440M |
| Prestige Consumer HealthcarePBH | $1.1B | $190M |
| EmbectaEMBC | $1.1B | $95.4M |
| Acadia PharmaceuticalsACAD | $1.1B | $391M |
| Legend BiotechLEGN | $1.0B | −$297M |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Prestige Consumer Healthcare — Key figures |url=https://companiesranked.com/en/company/prestige-consumer-healthcare |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Prestige Consumer Healthcare — Key figures. CompaniesRanked. https://companiesranked.com/en/company/prestige-consumer-healthcareBibTeX
@misc{companiesranked-en-company-prestige-consumer-healthcare-2026,
author = {{CompaniesRanked}},
title = {{Prestige Consumer Healthcare — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/prestige-consumer-healthcare}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001295947-26-000016 · May 14, 2026
{{cite web |title=Prestige Consumer Healthcare — Key figures — 10-K (0001295947-26-000016) |url=https://www.sec.gov/Archives/edgar/data/1295947/000129594726000016/pbh-20260331.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-05-14}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.